---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-025791"
form_type: "8-K"
ticker: "CYCN"
cik: "0001755237"
company_name: "Cyclerion Therapeutics, Inc."
filed_at: "2022-11-29T23:59:59+00:00"
generated_at: "2026-06-21T12:22:09.002382+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclerion gets 180-day bid price extension; transfers to Nasdaq Capital Market

## Summary
- Nasdaq granted extension to May 29, 2023 to regain $1.00 minimum bid price compliance.
- Company transferred from Nasdaq Global Market to Capital Market on Nov 25, 2022.
- Bid price below $1.00 for 30 consecutive business days; needs 10 consecutive days at $1.00+.
- If not cured by May 29, 2023, common stock will be delisted (subject to appeal).
- Company intends to cure deficiency via reverse stock split, if necessary.

## SEC filing metadata
- accession: 0000950170-22-025791
- form_type: 8-K
- ticker: CYCN
- cik: 0001755237
- company_name: Cyclerion Therapeutics, Inc.
- filed_at: 2022-11-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1755237/000095017022025791/0000950170-22-025791-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1755237/000095017022025791/cycn-20221129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-025791
- JSON: https://secwatch.observer/filing/0000950170-22-025791.json
- Plain text: https://secwatch.observer/filing/0000950170-22-025791.txt

## Key facts
- Listing & Compliance Notices
  Cyclerion Therapeutics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: a minimum of 10 consecutive business days as required under the Compliance Period Rule, the Staff will provide written notification to the Company that it complies with the Bid Price Requirement, unless the Staff exercises its discretion to extend this 10 day period pursuant to Nasdaq Listing Rule 5810(c)(3)(H). If the Company does not regain compliance with the Bid Price Requirement by the Extended Compliance Date, the Staff will provide written notification to the Company that its common stock will be delisted. At that time, the Company may appeal the Staff’s delisting determination to a Na
  evidence_url: https://www.sec.gov/Archives/edgar/data/1755237/000095017022025791/0000950170-22-025791-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.